New generation of ZEISS EVO scanning electron microscope introduced

Modular platform for intuitive operation, routine investigations and research applications JENA/Germany ZEISS presents the new generation of its proven high performance scanning electron microscope (SEM): The new instruments of the ZEISS EVO family come with a variety of improvements regarding usability, image quality and seamless integration into multimodal workflows. With its comprehensive range of available [...]

Genohm Achieves ISO 9001:2015 Certification

LAUSANNE, Switzerland -- Genohm, the makers of SLIMS, the LIMS+ELN platform, has successfully achieved ISO 9001:2015 certification. ISO 9001 is an internationally recognized standard that specifies the requirements for a Quality Management System (QMS) in a company. QMS impacts a company at every level, from daily administrative operations, to product development, marketing and sales, and through post-market customer [...]

HT1500L: No Frills HPLC Autosampler – it delivers what you truly need.

Is your HPLC routine calling for automation? Look no further than the HT1500L: an autosampler specifically designed for HPLC, fully equipped with all the powerful features any HPLC technician would naturally choose. HT15000L is the new born HPLC autosampler by HTA that offers the best balance of quality and affordability and that is perfectly compatible [...]

Cancer Genetics, Inc. is Among the First To Drive New FDA-Approved Testing Paradigm for Non-Small Cell Lung Cancer Patients by Offering Thermo Fisher Scientific’s Oncomine Dx Target Test

Thermo Fisher’s multi-biomarker test helps match lung cancer patients to FDA-approved therapies in days instead of weeks CGI and Thermo Fisher are collaborating with pharmaceutical partners and clinical cancer centers to drive adoption and improve therapy selection process Oncomine Dx Target Test eliminates time-consuming, single-biomarker testing approach by simultaneously screening patient tumor samples for 23 [...]

Schrödinger Appoints Dov Goldstein, M.D., as Chief Financial Officer

NEW YORK, NY– Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, today announced the appointment of Dov Goldstein, M.D., as Chief Financial Officer. Dr. Goldstein brings to Schrödinger over 20 years of strategic financial experience in the healthcare sector, most recently as a Managing Partner at Aisling Capital, a [...]

General Manager of Cell Signaling Technology China, Jay Dong, is Elected Co-President of Chinese Society for Cell Biology’s Academia-Industry Consortium for Innovation and Entrepreneurship

Xiamen, China – Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services, has announced that Jay Dong, General Manager of its China operations, has been elected Co-President of the Chinese Society for Cell Biology’s Academia-Industry Consortium for Innovation and Entrepreneurship. This consortium was formed to support translation of basic research into translational medicine. [...]

Innovate UK Awards Grant to MiNA Therapeutics and LGC LINK

LGC LINK, the oligonucleotide synthesis reagent manufacturing part of LGC's Genomics division, and MiNA Therapeutics, the pioneer in RNA activation therapeutics, today announced that Innovate UK has awarded the two companies a grant to develop liver targeted gene activation therapies for the treatment of liver diseases. The grant of up to approximately £400,000, with additional funding from [...]

Cronin Group plc – Acquisition of OpenIOLabs Limited

Cronin Group (AIM: CRON), the AIM listed company focusing on digitizing chemistry, is pleased to announce the acquisition of OpenIOLabs Limited ("OpenIOLabs") which specialises in developing hardware and software for scientific and industrial uses (the "Acquisition"). Pursuant to the Acquisition, Dr David Cleevely CBE FREng FIET, Chairman of OpenIOLabs, will be appointed as a non-executive director of [...]

Sarah Steele Chang Joins Bioz, Inc. as Vice President of Sales

Former Yelp executive to support the leader in zero bias life science recommendations in its next phase of growth   PALO ALTO, Calif. - Bioz, Inc., developers of the world's first and most comprehensive search engine for life science experimentation, today announced the appointment of Sarah Steele Chang as Vice President of Sales. Chang will be [...]

Hitachi Koki Announces Brand Name Change to “HiKOKI” 

TOKYO ‐‐ Hitachi Koki Co., Ltd., a leading manufacturer of power tools and life‐science  equipment, announced today that the company will change its corporate name to Koki Holdings Co., Ltd., effective  June 1, 2018, and will rebrand its full line of power tools known as HITACHI and/or Hitachi Koki under the new  HiKOKI1  (pronounced “hai‐koh‐key”) name, effective October 1, 2018. The name changes are in line with the  company’s ambitious international growth strategy, aimed at ensuring sustainable growth while expanding business  in the nearly 100 countries in Hitachi Koki’s global network. Hitachi Koki’s world‐class advanced technologies have produced reliable and innovative products throughout its  celebrated 70‐year history, which serve as the basis for its new partnership with KKR, one of the world’s pre‐ eminent private equity groups. Through the new partnership, Koki Holdings is streamlining operations and  accelerating investment in organic development and acquisitions to enhance its global businesses as a worldwide  leading manufacturer. Simultaneous to the rebranding efforts, the company is establishing a subsidiary as its European headquarters called  Koki Holdings Europe GmbH in the suburbs of Dusseldorf, Germany to reflect the strategic importance of the  European market. The subsidiary will commence operations in November 2017, and will serve to carry out the  parent company’s activities in Europe, with the aim to be closer to our customers to facilitate faster decision making  in managing their needs. “We have delivered award‐winning innovation in manufacturing with solid business performance for over 70 years,  and now is the time for us to focus on expansion as a truly global company while remaining rooted to our Japanese  tradition,” said Osami Maehara, President, Hitachi Koki. “We have fully committed to accelerate growth alongside a  dynamic new partner in KKR as we pursue our goal to become a global leader in power tools and life‐science  instruments. We have set an aggressive sales target of US$2.7 billion in fiscal year 2020. We are confident we can  take our business to the next level with the support of all our employees and partners worldwide, and the  revamping of the brand name is the first step to making this possible. We look forward to continuing to build a  brand that exceeds the expectations of discerning customers around the world.” 1    No changes will be made to the following brands in their respective markets: metabo, SANKYO, Tanaka, CARAT, HIT‐MIN,  himac. The  HiKOKI  brand  was  created  to  embody  the  three  core  competencies  of  the  company,  including  its  innovative  technologies that give rise to products with superior performance, the reliability of its products and services backed  by a 70‐year company history, and the potential for new business growth represented through the new partnership  with KKR. For ease of pronunciation, the new brand name uses a lowercase “i” in its first syllable, and includes  the implicit numeral “1” to express our commitment to providing our customers with the “No. 1” products on  the market, and our aim to achieve “No. 1” global status. The new corporate name, Koki Holdings Co., Ltd., is designed to maintain continuity with our current name, while  also reflecting the multiple brands it encompasses around the world, and accelerate our investment in acquisitions  [...]

Access IBO on Knowledge Center